GS-9876, A NOVEL, HIGHLY SELECTIVE, SYK INHIBITOR IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: SAFETY, TOLERABILITY AND EFFICACY RESULTS OF A PHASE 2 STUDY Kivitz, A., Mehta, D., Matzkies, F., Mozaffarian, A., Kunder, R., Di Paolo, J. A., Mozaffarian, N., Hsueh, S., Kim, J., Jiang, W., Liu, L., Sundy, J., Genovese, M. C. BMJ PUBLISHING GROUP. 2019: 746–47

View details for DOI 10.1136/annrheumdis-2019-eular.2144

View details for Web of Science ID 000472207102193